Navigation Links
Cumberland Pharmaceuticals Reports 24% Increase in Net Revenue With Full Year 2009 Financial Results
Date:3/10/2010

In addition to Cumberland's issued patent for Caldolor, the Company has filed the two new patent applications based on its clinical data for the product. Cumberland's research in hospitalized patients uncovered new findings for which the Company previously filed several provisional patent applications. Cumberland has now converted two of these provisional applications to full applications, which address the effect of intravenous ibuprofen in critically-ill, hospitalized patients as well as its effect on patient blood pressure.

Recent Developments

Cumberland intends to file a supplemental New Drug Application (sNDA) for Acetadote related to the product's ability to treat acute liver failure. Cumberland originally received FDA approval for Acetadote in 2004 for the treatment of acetaminophen overdose in adults, and has since expanded the product's label with a pediatric indication in 2006 and data further supporting the product's safety in 2008. This new sNDA submission is primarily based on a recent multicenter clinical study led by investigators at the University of Texas Southwestern Medical Center. The study results demonstrate that Acetadote is both safe and effective in treating patients suffering from acute liver failure, significantly improving transplant-free survival rates and reducing the number of patients requi
'/>"/>

SOURCE Cumberland Pharmaceuticals Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22

Related medicine technology :

1. Cumberland Pharmaceuticals to Announce Third Quarter 2009 Financial Results on November 10, 2009
2. Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor(R) in Australia and New Zealand
3. Cumberland Pharmaceuticals Donates Caldolor(R) to Haitian Relief Effort
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... 22, 2013 Hemoglobin A1C levels increased ... Type 2 diabetes, while modest improvements in A1C ... and can lead to substantial healthcare cost savings, ... Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th ... sponsored by Valeritas, makers of the V-Go ® ...
(Date:5/22/2013)... -- Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR ) today announced ... at the following conferences. , Deutsche Bank 38th ... 29, 2013 , Presentation time: 12:00 p.m. P.T. ... Presentation date: Wednesday June 5, 2013 , Presentation time: ... live webcast and 30-day archive of these presentations will be ...
(Date:5/22/2013)... , May 22, 2013  Grifols, a global ... , presented results from a study demonstrating that a ... Inhibitor [Human]) increased levels of the alpha 1 ... to levels that are considered within the normal range ... condition in which low levels of the alpha 1 ...
Breaking Medicine Technology:Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 2Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 3Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 4Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 5Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance 6Avanir Pharmaceuticals to Participate in Two Upcoming Investor Conferences 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 2Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 3Grifols study demonstrates higher dose of PROLASTIN-C increases levels of alpha1-PI to within normal range in patients with AAT deficiency 4
... Nov. 18, 2011 A new report released by ... spending on medical imaging is declining and Medicare patients ...  This analysis confirms earlier findings released by the American ... of the Coalition for Patient-Centered Imaging demonstrating that the ...
... 18, 2011 MedSolutions , a leading ... announced the launch of its Implantable Cardioverter Defibrillator ... to ensure the clinical appropriateness of ICD and ... With the cost of each ICD/CRT-D procedure averaging ...
Cached Medicine Technology:New Analysis Shows Downward Trend in Imaging Utilization 2MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 2MedSolutions Launches Implantable Cardiac Defibrillator Program to Reduce Unnecessary Surgeries 3
(Date:5/22/2013)... study suggests that disturbed sleep in adolescents is ... uncertainly about future success. However, perceived support ... have a protective effect. , Results show ... mood and greater uncertainty about future success. Higher ... teachers were associated with significantly fewer sleep disruptions ...
(Date:5/22/2013)... the parents are married are less likely to be ... the University of Houston. , "Childhood obesity is a ... one-third of all U.S. children ages 2-17 overweight or ... sociology at Rice and director of Rice,s Kinder Institute ... been conducted to explore the impact of family structure ...
(Date:5/22/2013)... May 22, 2013 Slip and fall ... by a number of factors. A December 2010 CDC ... following hazards as the most common: contaminants on the ... weather conditions, inadequate lighting, and lack of handrails (i). ... bruises, strained ligaments and muscles, fractures, broken bones, ...
(Date:5/22/2013)... Monroe, OH (PRWEB) May 22, 2013 ... indoor air quality merchandise ranging from furnace filters, ... DiscountFurnaceFilters.com is excited to add Stadler Form's ... a fashionable summer product line (fans, aroma diffusers ... , Stadler Form’s Otto Fan is the perfect ...
(Date:5/22/2013)... Peak Solar introduces unique, interactive solar training seminars, ... customers make informed buying choices. Research studies tell companies ... is to give them the tools needed to make ... heart. Solar training seminars will be introduced onto the ... solar kits . , Poised to help both residential ...
Breaking Medicine News(10 mins):Health News:Parent and teacher support protects teens from sleep problems and depression 2Health News:Children of married parents less likely to be obese 2Health News:Children of married parents less likely to be obese 3Health News:Law Firm Releases Slip and Fall Accident Informational Graphic to Show the Frequency and Cost of These Incidents 2Health News:Law Firm Releases Slip and Fall Accident Informational Graphic to Show the Frequency and Cost of These Incidents 3Health News:DiscountFurnaceFilter.com Now Offers Stadler Form Products - Providing Solutions to All Your Summer Needs 2Health News:Online Solar Training Seminars Aimed at Informing Consumers 2
... consumer focused new and improved interface. The most highlighting feature of ... cyber consumers to choose and buy their niche medicines any time. ... ... USA,s most reliable online pharmacy, launched a brand new customer focused, ...
... Multiple customer agreements for Soarian Clinicals and Siemens ... for the system that streamlines the flow of ... 5 Siemens ( ... customer contracts and installations, along with strong existing-customer ...
... allergies, so be prepared, expert says , , SUNDAY, April ... child is one of the more than 35 million Americans ... the youngster enjoy being outside, one expert says. , ... with MCG Pediatric Primary Care Associates and MCGHealth Children,s Medical ...
... of a Post-Merger Integration and Restructuring Practice. The new practice ... posed by increasing financial pressures and the consolidating health care market. ... ... Health Strategies & Solutions, Inc. (HS&S), the nation,s leading health ...
... man that suffers from depression, erectile dysfunction, fatigue, poor concentration or hot ... is advising men ages 35 and over to have their hormone levels ... 4 out of 5 men age 40 have low testosterone, the leading ... ...
... Mass., April 4 Inverness Medical Innovations, Inc. (NYSE: ... individuals to take charge of their health at home ... announced today that it will attend the upcoming Goldman ... Wednesday, April 8, 2009 at the Goldman Sachs Conference ...
Cached Medicine News:Health News:Rxonlinetoday Launch Cyber Shop for FDA Approved Medicines 2Health News:Rxonlinetoday Launch Cyber Shop for FDA Approved Medicines 3Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 2Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 3Health News:Siemens Announces Latest Contracts, Recent 'Go Lives,' and Strong Customer Support for its Workflow-Enhancing Healthcare IT Solution Soarian Clinicals, at HIMSS 2009 4Health News:Breathe Easier Knowing Spring's Pollen Triggers 2Health News:The Nation's Leading Health Care Strategy Firm Launches Post-Merger Integration Practice 2Health News:The Nation's Leading Health Care Strategy Firm Launches Post-Merger Integration Practice 3Health News:Male Hormone Treatment Provider Announces Family Doctor Alert 2Health News:Male Hormone Treatment Provider Announces Family Doctor Alert 3Health News:Male Hormone Treatment Provider Announces Family Doctor Alert 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: